Status:
UNKNOWN
Comparison of Conventional Dialysis and the Allient System
Lead Sponsor:
Renal Research Institute
Collaborating Sponsors:
Renal Solutions, Inc.
Conditions:
End Stage Renal Disease
Chronic Kidney Failure
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The purpose of the study to determine whether the level of inflammation may be decreased, the lifespan of red blood cells increased and the clearance of waste products in the blood improved through th...
Eligibility Criteria
Inclusion
- Maintenance in-center hemodialysis
- Age greater than or equal to 18 years
- Has been on hemodialysis for at least 4 months
- Uses a standard single-pass dialysis machine with a high-flux dialyzer
Exclusion
- Hospitalization during the 8 weeks preceding enrollment
- Infection requiring antibiotic treatment during the 8 weeks preceding enrollment
- Central venous cather as dialysis access
- Uncontrollable blood coagulation anomalies
- Smokers
- Dialysis regimen other than 3 times weekly
- In ability to understand the English language and give informed consent for participation in the study
Key Trial Info
Start Date :
November 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2014
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00788905
Start Date
November 1 2008
End Date
January 1 2014
Last Update
March 29 2013
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Irving Place Dialysis Center
New York, New York, United States, 10003
2
Upper Manhattan Dialysis Center
New York, New York, United States, 10025
3
Yorkville Dialysis Center
New York, New York, United States, 10128